#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypocalcaemia Pulmonary tuberculosis Biotinidase deficiency Gastrooesophageal cancer Andersen-Tawil syndrome Retinopathy proliferative Herpes simplex Dementia Alzheimer's type Ureteric cancer Nephropathy Frontotemporal dementia Endometrial cancer Chondrosarcoma Astrocytoma Primary biliary cholangitis More trials…

    Learn about Rare Diseases

    Systemic mastocytosis – Life with Disease Cystic fibrosis – Diagnostics Metachromatic leukodystrophy Undifferentiated sarcoma – Basic Information Adrenocortical carcinoma – Trials in Disease Cystic fibrosis – Treatment Chronic granulomatous disease – Basic Information Encephalitis autoimmune – Diagnostics Methylmalonic acidaemia – Basic Information Cystic fibrosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Zimberelimab Pelareorep Molidustat Sodium Vibozilimod Tasquinimod Vortioxetine Prednisolone Sodium Phosphate Rondaptivon Pegol Pregabalin Adg126 Dexamethasone Phosphate Corticosteroids, Plain CARBOMER 980 Norucholic Acid Abatacept Gadobenate Dimeglumine Mebufotenin Masitinib Oxcarbazepine BLEXIMENIB More therapies…

    Learn about Your Condition

    Embolic stroke Leukaemia Juvenile spondyloarthritis Femur fracture Bone hypertrophy Neuroblastoma Encephalitis autoimmune Myeloproliferative neoplasm Fabry's disease Colorectal cancer stage IV Renal cancer recurrent Non-small cell lung cancer Aicardi-Goutieres syndrome Chronic hepatitis C Pouchitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Safety and Effectiveness of Parecoxib and Sodium Chloride for Patients Hospitalized with Spontaneous Subarachnoid Hemorrhage

    Recruiting

    2 1 1
    Investigated Diseases:
    • Subarachnoid haemorrhage
    Investigated Drugs:
    • PARECOXIB
    • Sodium Chloride
    Czechia

  • Study of Tezepelumab effects on airway barrier function in patients with severe asthma, with or without chronic rhinosinusitis with nasal polyps

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Asthma
    • Chronic rhinosinusitis with nasal polyps
    Investigated Drugs:
    • Tezepelumab
    Austria

  • Study of drug combinations including cisplatin, carboplatin, doxorubicin, fluorouracil, vincristine, etoposide, irinotecan, gemcitabine, oxaliplatin and sorafenib for children with hepatoblastoma or hepatocellular carcinoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Sorafenib
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia France Germany Ireland +4

  • Study of Olaparib for Patients with Recurrent Ovarian Cancer Without BRCA Gene Mutations

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian cancer recurrent
    Investigated Drugs:
    • Olaparib
    Italy

  • Study of Lisaftoclax and Acalabrutinib for Patients with Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Chlorambucil
    • Cyclophosphamide Monohydrate
    • Acalabrutinib
    Bulgaria Czechia Spain

  • Study on Rituximab, Lenalidomide, and Tafasitamab for Treating High-Risk and Low-Risk Follicular Lymphoma Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Follicular lymphoma
    Investigated Drugs:
    • Tafasitamab
    • Lenalidomide
    • Rituximab
    Denmark Finland Iceland Norway Sweden
Previous Page
1 … 261 262 263 264 265 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!